Fostering International Paediatric Clinical Research
Paediatric multinational clinical trials are essential to boost paediatric research but also must face the difficulties transnational projects normally bring. PedCRIN final event focused on the challenges in international and multicentric paediatric clinical trials and included several panels where the setup, planning and conduction phases of these studies was discussed and analysed.
Additionally, our consortium experts presented the main outcomes of the project (i.e supporting tools, methodologies, identified gaps, etc.) and debated on future initiatives and collaborations.
Recording links
Part 1
Part 2
Agenda
 |
|
Welcome |
|
|
9:30 - 9:35 |
Welcome |
|
9:35 - 9:50 |
Introduction Jacques Demotes, European Clinical Research Infrastructure Network |
Setting the scene- Multinational paediatric clinical trials: challenges and benefits |
|
|
9:50 - 10:00 |
Introduction Session Chair Pirkko Lepola, Helsinki University Hospital |
|
10:00 - 10:10 |
YPAGs contribution to the PedCRIN project (To be confirmed) |
|
10:10 - 10:20 |
Investigator perspective Siri Merete Brændvik, St.Olavs University Hospital/Norwegian University of Science and Technology |
|
10:20 - 10:30 |
Academic sponsor perspective Rabia Hussain, University College Dublin |
|
10:30 - 10:40 |
Questions and Discussion |
Planning phase: PedCRIN response (Support to the design and set-up) |
|
|
10:40 - 10:45 |
Introduction Session Chair Saskia de Wildt, Radboud University Medical Center |
|
10:45 - 10:55 |
PedCRIN Survey results Lucia Ruggieri, Gianni Benzi Pharmacological Research Foundation |
|
10:55 - 11:10 |
Tools developed (WP3 and WP5) |
|
Evelyne Jacqz-Aigrain, The French National Institute of Health and Medical Research |
|
|
Cristina Manfredi, Consorzio per Valutazioni Biologiche e Farmacologiche |
|
|
Begonya Nafria Escalera, Hospital Sant Joan de Déu |
|
|
Eric Vermeulen, Patient Alliance for Rare and Genetic Diseases |
|
|
11:10 - 11:30 |
Questions and Answers |
|
11:30 - 11:40 |
BREAK |
Conduct phase: PedCRIN response- (Support to the conduct and management) |
|
|
11:40 - 12:15 |
Panel discussion to address the conduct and management phase, the tools developed for the management, the importance of qualified resources (involvement of national network of clinical trials units with feedback from CTUs involved) and operational questions such as ethics & regulatory issues, data etc. |
|
Session Chair: Saskia de Wildt, Radboud University Medical Center |
|
|
Panelists: |
|
|
Kateřina Nebeská, Masaryk University |
|
|
Kristyna Noskova, European Clinical Research Infrastructure Network |
|
|
Pascale Wenger, Swiss Clinical Trial Organisation |
|
|
Sabine Klager, European Clinical Research Infrastructure Network |
|
|
Rabia Hussain, University College Dublin |
|
|
Colm O'Donnell, University College Dublin & National Maternity Hospital |
|
The future- Beyond PedCRIN project- Synergies with the existing networks and initiatives, how the paediatric community can benefit from on-going ECRIN activities |
|
|
12:15 - 12:25 |
Introduction Session Chair Donato Bonifazi, Consorzio per Valutazioni Biologiche e Farmacologiche |
|
12:25 - 12:45 |
Synergy with c4c project Mark Turner, University of Liverpool, |
|
Synergy with ERNs –EJP-RD, Luca Sangiorgi, Rizzoli Orthopaedic Institute |
|
|
Beyond PedCRIN-ECRIN activities of interest for the paediatric community Jacques Demotes, European Clinical Research Infrastructure Network |
|
|
12:45 - 12:55 |
Questions and Discussion |
|
12:55 - 13:00 |
Closing remarks Jacques Demotes and EU commission (To be confirmed) |
|
|
|
